Shield Therapeutics plc (AIM: STX)

Shield Therapeutics Revenue

Shield Therapeutics had revenue of $12.13M USD in the half year ending June 30, 2024, with 364.12% growth. This brings the company's revenue in the last twelve months to $21.47M, up 223.99% year-over-year. In the year 2023, Shield Therapeutics had annual revenue of $13.09M with 137.95% growth.

• Revenue (ttm): $21.47M
• Revenue Growth: +223.99%
• P/S Ratio: 1.20
• Revenue / Employee: $294.16K
• Employees: 73
• Market Cap: 20.92M GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	13.09M	7.59M	137.95%
Dec 31, 2022	5.50M	3.98M	262.01%
Dec 31, 2021	1.52M	-8.87M	-85.38%
Dec 31, 2020	10.39M	9.67M	1,344.65%
Dec 31, 2019	719.00K	-11.16M	-93.95%